Russell D. Cohen, MD
Dr. Cohen is Associate Professor of Medicine in the Department of Medicine/Section of Gastroenterology at the University of Chicago in Illinois. In addition, he is Co-Director of Clinical...
Read More
Marc D. Cohen, MD
Dr. Cohen is Professor of Medicine with the National Jewish Medical and Research Center in Denver, Colorado. Dr. Cohen graduated from the George University School of Medicine and Health Science...
Read More
Pharmaceutical marketing clearly influences the prescribing decisions made by health professionals. Evidence suggests that this influence increases cost of care, is often underestimated and can supersede providers’ preferred drug choice. Unfortunately, most health professional students indicate that their training regarding interactions with the pharmaceutical industry is inadequate. This interactive module seeks to remedy this problem and fill this void in order to improve prescribing behaviors in physicians and other health care providers.
The International Journal of Advances in Rheumatology, a CME/CPE/CNE-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of rheumatoid diseases. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that will have most impact on their day-to-day practice and is designed to provide management options for...
Read More
Opioid addiction is a significant public health problem in the United States, associated with the spread of infectious diseases, crime, premature death, and significant psychiatric and medical comorbidities. There are an estimated 1 million people meeting Diagnostic and Statistical Manual-IV criteria for prescription opioid dependence according to the National Survey on Drug Use and Health and an additional 1 million people addicted to heroin according to the Office of National Drug Control...
Read More
Cardiovascular (CV) disease remains the leading cause of mortality in the United States. Compared with age-matched persons in the general population, kidney transplant recipients are at a greater than 10-fold increased risk of CV mortality. Indeed, CV disease is responsible for approximately 50% of death with function after the first post-transplant year. Maintenance of CV health has emerged as a top priority in the long-term management of renal transplant recipients. Read More
